What is Vvardis?
Headquartered in Zug, Switzerland, Vvardis is a specialized healthcare company dedicated to the development of groundbreaking biomimetic, non-invasive dental solutions. Founded by Drs. Haley and Goly Abivardi, the firm represents over 25 years of rigorous scientific research aimed at addressing unmet needs in oral health. The company's flagship brand, Curodont, serves as a testament to its commitment to innovation, providing dental professionals with advanced tools that prioritize patient comfort and long-term oral health outcomes. By focusing on underserved populations and leveraging a deep understanding of dental physiology, Vvardis has established a distinct market position that bridges the gap between clinical efficacy and patient-centric care.
How much funding has Vvardis raised?
Vvardis has raised a total of $85M across 2 funding rounds:
Other Financing Round
$35M
Other Financing Round
$50M
Other Financing Round (2025): $35M with participation from OrbiMed
Other Financing Round (2025): $50M led by OrbiMed
Key Investors in Vvardis
OrbiMed
OrbiMed Advisors LLC is a specialized investment firm focused on the healthcare sector, managing capital across biopharmaceuticals, medical devices, and digital health platforms to support innovation at various stages of development.
What's next for Vvardis?
With the recent influx of capital, Vvardis is poised to execute an aggressive expansion strategy aimed at broadening the reach of its Curodont brand across international markets. The company's roadmap likely includes scaling its manufacturing capabilities to meet rising demand and investing in further clinical validation to support its non-invasive treatment protocols. As the firm matures, it will likely focus on strengthening its commercial infrastructure and forging strategic partnerships with dental networks to solidify its footprint in the global medtech ecosystem. The focus remains on maintaining its competitive edge through continuous innovation while navigating the complexities of the global dental healthcare market.
See full Vvardis company page
